Literature DB >> 8879229

Gene vaccination with naked plasmid DNA: mechanism of CTL priming.

M Corr1, D J Lee, D A Carson, H Tighe.   

Abstract

The injection of naked plasmid DNA directly into the muscle cells of mice has been shown to induce potent humoral and cellular immune responses. The generation of a cytotoxic T lymphocyte (CTL) response after plasmid DNA injection may involve the presentation of the expressed antigen in the context of the injected myocytes' endogenous major histocompatibility (MHC)-encoded class I molecules or may use the MHC molecules of bone marrow-derived antigen presenting cells (APC) which are capable of providing co-stimulation as well. To resolve which cell type provides the specific restricting element for this method of vaccination we generated parent-->F1 bone marrow chimeras in which H-2bxd recipient mice received bone marrow that expressed only H-2b or H-2d MHC molecules. These mice were injected intramuscularly with naked plasmid DNA that encoded the nucleoprotein from the A/PR/8/34 influenza strain, which as a single antigen has epitopes for both H-2Db and H-2Kd. The resulting CTL responses were restricted to the MHC haplotype of the bone marrow alone and not to the second haplotype expressed by the recipient's myocytes. The role of somatic tissues that express protein from injected plasmids may be to serve as a reservoir for that antigen which is then transferred to the APC. Consequently, our data show that the mechanism of priming in this novel method for vaccination uses the MHC from bone marrow-derived APC, which are efficient at providing all of the necessary signals for priming the T cell.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879229      PMCID: PMC2192808          DOI: 10.1084/jem.184.4.1555

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

Authors:  R Suto; P K Srivastava
Journal:  Science       Date:  1995-09-15       Impact factor: 47.728

Review 2.  Exposing the immunology of naked DNA vaccines.

Authors:  D M Pardoll; A M Beckerleg
Journal:  Immunity       Date:  1995-08       Impact factor: 31.745

3.  Fibroblasts as efficient antigen-presenting cells in lymphoid organs.

Authors:  T M Kündig; M F Bachmann; C DiPaolo; J J Simard; M Battegay; H Lother; A Gessner; K Kühlcke; P S Ohashi; H Hengartner
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

4.  In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter.

Authors:  A Y Huang; A T Bruce; D M Pardoll; H I Levitsky
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

Review 5.  DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.

Authors:  R G Whalen; C Leclerc; E Dériaud; R Schirmbeck; J Reimann; H L Davis
Journal:  Ann N Y Acad Sci       Date:  1995-11-27       Impact factor: 5.691

6.  DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein.

Authors:  H L Davis; R Schirmbeck; J Reimann; R G Whalen
Journal:  Hum Gene Ther       Date:  1995-11       Impact factor: 5.695

7.  Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation.

Authors:  R Schirmbeck; K Melber; J Reimann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

8.  Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.

Authors:  W Böhm; R Schirmbeck; A Elbe; K Melber; D Diminky; G Kraal; N van Rooijen; Y Barenholz; J Reimann
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

9.  Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.

Authors:  B Martinez-Kinader; G B Lipford; H Wagner; K Heeg
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

10.  Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.

Authors:  C Reis e Sousa; R N Germain
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  84 in total

1.  Induction of antiviral antibodies by DNA immunization requires neither perforin-mediated nor CD8(+)-T-cell-mediated lysis of antigen-expressing cells.

Authors:  D E Hassett; J Zhang; J L Whitton
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 2.  The influence of base sequence on the immunostimulatory properties of DNA.

Authors:  D S Pisetsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.

Authors:  G Deliyannis; J S Boyle; J L Brady; L E Brown; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Intralymphatic immunization enhances DNA vaccination.

Authors:  K J Maloy; I Erdmann; V Basch; S Sierro; T A Kramps; R M Zinkernagel; S Oehen; T M Kündig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 5.  Strategies for improving responses to DNA vaccines.

Authors:  J S Boyle; I G Barr; A M Lew
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

6.  Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product.

Authors:  Stéphanie Mercier; Hanne Gahéry-Segard; Martine Monteil; Renée Lengagne; Jean-Gérard Guillet; Marc Eloit; Caroline Denesvre
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 7.  Dendritic cell delivery of plasmid DNA. Applications for controlled genetic immunization.

Authors:  R J Mumper; H C Ledebur
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

8.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

9.  Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells.

Authors:  R E Tascon; S Ragno; D B Lowrie; M J Colston
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 10.  Applications of major histocompatibility complex class I molecules expressed as single chains.

Authors:  Tina Primeau; Nancy B Myers; Y Y Lawrence Yu; Lonnie Lybarger; Xiaoli Wang; Steven M Truscott; Ted H Hansen; Janet M Connolly
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.